Login / Signup

Preliminary Study of the Distinctive Mechanism of Shenqi Compound in Treating Rats with Type 2 Diabetes Mellitus by Comparing with Metformin.

Xiaoxu FuXiujuan ZhouYa LiuYuanhong LeiHongyan XieYulin LengHong GaoChunguang Xie
Published in: Current vascular pharmacology (2023)
Comparing SQC with metformin to treat T2DM rats revealed several potential gene targets. These genes provide clues for elucidating the therapeutic mechanisms of SQC.
Keyphrases
  • genome wide
  • genome wide identification
  • type diabetes
  • copy number
  • single cell
  • genome wide analysis
  • dna methylation
  • risk assessment
  • human health
  • climate change
  • adipose tissue
  • glycemic control